Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study

International Journal of Obesity

Volumn 36, Issue 2, 2012, Pages 218-224

  Lamri, A ^a,b   Abi Khalil, C ^a,b,c   Jaziri, R ^a,b   Velho, G ^a   Lantieri, O ^d   Vol, S ^d   Froguel, P ^e,f   Balkau, B ^g,h   Marre, M ^a,b,c   Fumeron, F ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d IRSA Institut Inter Régional Pour la Santé   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

body mass index; fat intake; gene environment interactions; genetic variation; PPARG; type 2 diabetes

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADULT; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; DNA POLYMORPHISM; FAT INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE LOCUS; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FEMALE; FRANCE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84857051628     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.91     Document Type: Article

References (31)

1. Andreasen CH, Andersen G. Gene-environment interactions and obesityFfurther aspects of genomewide association studies. Nutrition 2009; 25: 998-1003.
2. Anghel SI, Wahli W. Fat poetry: A kingdom for PPAR gamma. Cell Res 2007; 17: 486-511. (Pubitemid 46980946)
3. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 1997; 272: 18779-18789. (Pubitemid 27318225)
4. Mueller E, Drori S, Aiyer A, Yie J, Sarraf P, Chen H et al. Genetic analysis of adipogenesis through peroxisome proliferator-Activated receptor gamma isoforms. J Biol Chem 2002; 277: 41925-41930. (Pubitemid 35257505)
5. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997; 241: 270-274. (Pubitemid 28020091)
6. Jaziri R, Lobbens S, Aubert R, Pean F, Lahmidi S, Vaxillaire M et al. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: The Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 2006; 55: 1157-1162. (Pubitemid 44100195)
7. Masugi J, Tamori Y, Mori H, Koike T, Kasuga M. Inhibitory effect of a proline-to-Alanine substitution at codon 12 of peroxisome proliferator-Activated receptor-gamma 2 on thiazolidinedioneinduced adipogenesis. Biochem Biophys Res Commun 2000; 268: 178-182. (Pubitemid 30116630)
8. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316: 1331-1336. (Pubitemid 46871653)
9. Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M et al. Heterogeneous effect of peroxisome proliferator-Activated receptor gamma2 Ala12 variant on type 2 diabetes risk. Obesity (Silver Spring) 2007; 15: 1076-1081. (Pubitemid 46932461)
10. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-Analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182. (Pubitemid 36177070)
11. Memisoglu A, Hu FB, Hankinson SE, Liu S, Meigs JB, Altshuler DM et al. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes. Diabetes Care 2003; 26: 2915-2917. (Pubitemid 37205568)
12. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287. (Pubitemid 28507675)
13. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS et al. Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and noninsulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 2000; 24: 195-199. (Pubitemid 30107568)
14. Tonjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-Activated receptor gamma with pre-diabetic phenotypes: Meta-Analysis of 57 studies on nondiabetic individuals. Diabetes Care 2006; 29: 2489-2497. (Pubitemid 44912258)
15. Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb SS et al. Two polymorphisms in the peroxisome proliferatoractivated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999; 84: 3708-3712. (Pubitemid 30645229)
16. Ek J, Urhammer SA, Sorensen TI, Andersen T, Auwerx J, Pedersen O. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-Activated receptor-gamma2 (PPAR-gamma2): Divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 1999; 42: 892-895. (Pubitemid 29325082)
17. Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin LJ et al. Association of the Pro12Ala variant in the peroxisome proliferator-Activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes 1998; 47: 1806-1808. (Pubitemid 28476259)
18. Masud S, Ye S. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: A meta-Analysis. J Med Genet 2003; 40: 773-780. (Pubitemid 37311078)
19. Doney A, Fischer B, Frew D, Cumming A, Flavell DM, World M et al. Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 2002; 3: 21.
20. Doney AS, Fischer B, Cecil JE, Boylan K, McGuigan FE, Ralston SH et al. Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes. Diabetologia 2004; 47: 555-558. (Pubitemid 38491254)
21. Wei Q, Jacobs Jr. DR, Schreiner PJ, Siscovick DS, Steffes MW, Fornage M. Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: The CARDIA Study. J Mol Med 2006; 84: 955-965. (Pubitemid 44655873)
22. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC et al. Interaction between a peroxisome proliferatoractivated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 2003; 12: 2923-2929. (Pubitemid 37442020)
23. Luan J, Browne PO, Harding AH, Halsall DJ, O'Rahilly S, Chatterjee VK et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 2001; 50: 686-689. (Pubitemid 32195237)
24. Vaccaro O, Lapice E, Monticelli A, Giacchetti M, Castaldo I, Galasso R et al. Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients. Diabetes Care 2007; 30: 1156-1161. (Pubitemid 46684641)
25. Heikkinen S, Argmann C, Feige JN, Koutnikova H, Champy MF, Dali-Youcef N et al. The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface. Cell Metab 2009; 9: 88-98.
26. Robitaille J, Despres JP, Perusse L, Vohl MC. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: Results from the Quebec Family Study. Clin Genet 2003; 63: 109-116. (Pubitemid 36949904)
27. Balkau B. An epidemiologic survey from a network of French Health Examination Centres (D.E.S.I.R.): Epidemiologic data on the insulin resistance syndrome. Rev Epidemiol Sante Publique 1996; 44: 373-375.
28. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
29. Lasfargues G, Vol S, Le Clesiau H, Bedouet M, Hagel L, Constans T et al. Validity of a short self-Administered dietary questionnaire compared with a dietetic interview. Presse Med 1990; 19: 953-957. (Pubitemid 20186659)
30. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: Testing haplotype effects in association studies. Bioinformatics 2007; 23: 1038-1039. (Pubitemid 47050595)
31. Vaxillaire M, Veslot J, Dina C, Proenca C, Cauchi S, Charpentier G et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 2008; 57: 244-254.